CeriBell Inc.
CBLL | NASDAQ
$24.25
-$0.12 (-0.49%)
At close: Sep 21, 2026, 4:00 PM ET
$24.73
+$0.48 (+1.98%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Company Profile
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Key Executives
| Name | Position |
|---|---|
| Xingjuan Chao | Co-Founder, President, Chief Executive Officer & Director |
| Raymond Woo | Chief Technology Officer |
| Scott Blumberg | Chief Financial Officer |
| Baharan Kamousi | Senior Vice President of Data Science |
| Brian Price | Senior Vice President of Marketing |
| Dan Rogy | Senior Vice President of Operations |
| Josef Parvizi | Co-Founder, Chief Medical Advisor & Director |
| Joseph S. Manni | Chief Revenue Officer |
| Kim McKeon | Vice President of People & Culture |
| Louisa Daniels | General Counsel |
CeriBell Inc.
| Country | United States |
| IPO Date | Oct 10, 2024 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 327 |
| CEO | Xingjuan Chao |
Contact Details
360 North Pastoria Avenue Sunnyvale,
California 94085 United States
Stock Details
| Ticker Symbol | CBLL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001861107 |
| CUSIP Number | 15678C102 |
| ISIN Number | US15678C1027 |
| SIC Code | 3845 |
Add to Watchlist
Select watchlists to add or remove CBLL